What is the study about?
The purpose of the ENCHANT study is to determine whether screening for sleep apnea using a Home Sleep Apnea Test, compared to the current standard care using an in-laboratory sleep study, increases the number of patients with cognitive impairment diagnosed and treated for sleep apnea.
Eligibility- Who can participate?
Participants must be:
- diagnosed with cognitive impairment (e.g. Alzheimer’s disease, mild cognitive impairment, vascular dementia, vascular mild cognitive impairment, Parkinson’s disease-related dementia, etc.)
- Available to complete overnight sleep testing (at home or in-hospital), as well as clinical and follow-up assessments
- Not using a CPAP or dental appliance for Obstructive Sleep Apnea
- Not have a diagnosis of Obstructive Sleep Apnea in the past 2 years
- Initial baseline appointment: assessments and questionnaires (related to cognition, sleep, function, mood and behavior) and sleep study assessment (at home or in-hospital)
- 6-month follow-up assessments and questionnaires (related to cognition, sleep, function, mood and behavior)
- 12-month follow-up phone call
TDRA Study Investigators
Dr. Mark Boulos
Sunnybrook Health Sciences Centre